CM4410-3103 Screening compound: 1-({3-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]phenyl}methyl)-4-(2-methoxyethyl)-1,4-diazaspiro[5.5]undecan-3-one

CM4410-3103 Screening compound: 1-({3-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]phenyl}methyl)-4-(2-methoxyethyl)-1,4-diazaspiro[5.5]undecan-3-one
CM4410-3103 Screening compound: 1-({3-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]phenyl}methyl)-4-(2-methoxyethyl)-1,4-diazaspiro[5.5]undecan-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound CM4410-3103
1-({3-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]phenyl}methyl)-4-(2-methoxyethyl)-1,4-diazaspiro[5.5]undecan-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

CM4410-3103

Molecular Formula

C25H35N3O4 (C25 H35 N3 O4)

Compound Name

1-({3-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]phenyl}methyl)-4-(2-methoxyethyl)-1,4-diazaspiro[5.5]undecan-3-one

IUPAC name

1-({3-[(35-dimethyl-12-oxazol-4-yl)methoxy]phenyl}methyl)-4-(2-methoxyethyl)-14-diazaspiro[5.5]undecan-3-one

SMILES

Cc1noc(C)c1COc1cccc(CN(C2)C3(CCCCC3)CN(CCOC)C2=O)c1

InChI

InChI=1S/C25H35N3O4/c1-19-23(20(2)32-26-19)17-31-22-9-7-8-21(14-22)15-28-16-24(29)27(12-13-30-3)18-25(28)10-5-4-6-11-25/h7-9,14H,4-6,10-13,15-18H2,1-3H3

InChI Key

MUFPERLZWSSWCE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD30458889

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

441.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.091

Distribution Coefficient, logD

2.739

Water Solubility, LogSw

-3.17

Polar Surface Area

57.967

Acid Dissociation Constant (pKa)

22.04

Base Dissociation Constant (pKb)

7.50

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

60.00

CM4410-3103 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS BBB Library (22607 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with CM4410-3103 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound CM4410-3103?
Check Price and Availability of CM4410-3103, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of CM4410-3103 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for CM4410-3103
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for CM4410-3103
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of CM4410-3103 available by request